Arsenal Capital Partners is a progressive private equity firm that
facilitates transformational growth and change through a
collaborative approach.
Arsenal Capital Partners Announces Sale of IDQ
Realization Yields Nearly 8x Multiple of Investment
Arsenal Completes Genovique Sale
Arsenal Capital Partners Continues 2010 Momentum With Completion Of Genovique Specialties Sale To Eastman Chemical
NEW YORK, May 3, 2010 – Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle market specialty industrial, healthcare and financial services companies, continued its significant momentum in 2010 with the completion of its previously announced sale of portfolio company Genovique Specialties Corporation, a leading global provider of benzoate plasticizers, to Eastman Chemical Company (NYSE: EMN).
Tim Zappala, Chairman of Genovique, and a partner of Arsenal Capital who co-heads the firm's specialty chemicals...
FrontStream Payments, Inc. Announces Acquisition of Fast Transact, Inc. and Investment by Arsenal Capital Partners
Acquisition Broadens the Suite of Differentiated Payments Solutions and Positions the Platform for Continued Growth
BRENTWOOD, TN - March 19, 2010 – FrontStream Payments, Inc., a national provider of payment solutions, today announced the acquisition of Fast Transact, Inc., a leading provider of innovative payment processing solutions for e-commerce and physical points of sale. The acquisition was funded through an investment by Arsenal Capital Partners.
"The acquisition of Fast Transact strengthens FrontStream's approach of providing customers with unique, high value payment products. Fast Transact's secure, integrated payment solutions and its experienced management...
Arsenal Sells Genovique
Arsenal Capital Partners Announces Definitive Agreement To Sell Genovique Specialties Corporation To Eastman Chemical
NEW YORK, March 17, 2010 – Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle-market specialty industrial, healthcare, and financial services companies, today announced that it has entered into a definitive agreement with Eastman Chemical Company (NYSE: EMN) to sell its portfolio company Genovique Specialties Corporation, a leading global provider of benzoate plasticizers.
Genovique Specialties, headquartered in Rosemont, IL, is a global producer of benzoic acid, sodium benzoate and specialty plasticizers...
Arsenal Capital Announces Promotions of Gorbach and Seroussi
Eugene Gorbach Promoted to Vice President and Roy Seroussi Promoted to Senior Associate
NEW YORK, February 2, 2010 – Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle-market specialty industrial, healthcare, and financial services companies, today announced the promotions of Eugene Gorbach to Vice President and Roy Seroussi to Senior Associate.
Carty Chock, a Principal of Arsenal Capital, said, “We are proud of our team of executives. The development of our talented professionals is a key area of focus for Arsenal. Gene has made significant contributions to Arsenal’s Financial...
IMDS (Innovative Medical Device Solutions) acquires Cencast Corporation
Logan, UT, January 26, 2009 - IMDS announced the completion of the acquisition of Cencast Corporation, a company based in Molalla, Oregon, that provides conventional and innovative precision metal casting solutions to the medical device industry. This acquisition further expands IMDS’ position as a premier outsourcing partner for medical device OEM’s.
“Cencast Corporation, as part of IMDS, will bring improved lead times to our customers who outsource products that are manufactured from castings,” stated Wade Fallin, President and CEO of...